PL409207A1 - Sposób wytwarzania produktu kosmetycznego - Google Patents
Sposób wytwarzania produktu kosmetycznegoInfo
- Publication number
- PL409207A1 PL409207A1 PL409207A PL40920714A PL409207A1 PL 409207 A1 PL409207 A1 PL 409207A1 PL 409207 A PL409207 A PL 409207A PL 40920714 A PL40920714 A PL 40920714A PL 409207 A1 PL409207 A1 PL 409207A1
- Authority
- PL
- Poland
- Prior art keywords
- cosmetic product
- producing
- range
- subjecting
- mpa
- Prior art date
Links
- 239000002537 cosmetic Substances 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 230000002706 hydrostatic effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
Wynalazek polega na poddaniu mieszaniny czynnych i nośnych składników produktu kosmetycznego co najmniej jednokrotnemu oddziaływaniu ciśnienia hydrostatycznego wybranego z zakresu od 50 do 600 MPa w temperaturze wybranej z zakresu od 5 do 50°C i przez okres nie krótszy niż 3 minuty.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL409207A PL409207A1 (pl) | 2014-08-18 | 2014-08-18 | Sposób wytwarzania produktu kosmetycznego |
| PCT/IB2014/065452 WO2016027137A1 (en) | 2014-08-18 | 2014-10-19 | Process for making cosmetic product |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL409207A PL409207A1 (pl) | 2014-08-18 | 2014-08-18 | Sposób wytwarzania produktu kosmetycznego |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL409207A1 true PL409207A1 (pl) | 2016-02-29 |
Family
ID=52007234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL409207A PL409207A1 (pl) | 2014-08-18 | 2014-08-18 | Sposób wytwarzania produktu kosmetycznego |
Country Status (2)
| Country | Link |
|---|---|
| PL (1) | PL409207A1 (pl) |
| WO (1) | WO2016027137A1 (pl) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL422649A1 (pl) * | 2017-08-25 | 2019-03-11 | Instytut Wysokich Ciśnień Polskiej Akademii Nauk | Kompozycje i sposób wytwarzania innowacyjnych naturalnych emolientów wykorzystaniem proekologicznej metody HPP lub HPP+ |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL437317A1 (pl) * | 2021-03-16 | 2021-12-13 | Jerzy Jurasz | Sposób wysokociśnieniowego przetwarzania zwłaszcza płynów i linia technologiczna do wysokociśnieniowego przetwarzania zwłaszcza płynów |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6635223B2 (en) * | 2000-10-25 | 2003-10-21 | Andreas Maerz | Method for inactivating micro-organisms using high pressure processing |
| JP2007509617A (ja) * | 2003-11-03 | 2007-04-19 | コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガニゼイション | 胞子不活性化プロセス |
| JP2008115308A (ja) * | 2006-11-07 | 2008-05-22 | Univ Soka | 香水の製造方法 |
-
2014
- 2014-08-18 PL PL409207A patent/PL409207A1/pl unknown
- 2014-10-19 WO PCT/IB2014/065452 patent/WO2016027137A1/en not_active Ceased
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL422649A1 (pl) * | 2017-08-25 | 2019-03-11 | Instytut Wysokich Ciśnień Polskiej Akademii Nauk | Kompozycje i sposób wytwarzania innowacyjnych naturalnych emolientów wykorzystaniem proekologicznej metody HPP lub HPP+ |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2016027137A1 (en) | 2016-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2017003965A (es) | Metodo para elaborar productos perfumados. | |
| MX2024012899A (es) | Metodos y composiciones relacionadas con crispr/cas para el tratamiento de beta hemoglobinopatias | |
| EP4516319A3 (en) | Subcutaneous formulations of anti-cd38 antibodies and their uses | |
| PH12018500711A1 (en) | Anti-pd1 antibodies and methods of use | |
| PH12018500363A1 (en) | Bispecific monovalent diabodies that are capable of binding b7-h3 and cd3, and uses thereof | |
| MY191581A (en) | Anti-pd-1 antibodies | |
| MY186334A (en) | Anti-her2 antibodies and immunoconjugates | |
| MX2018009325A (es) | Compuestos y metodos para tratar enfermedades mediadas por el acido ribonucleico (arn). | |
| SG10201804931QA (en) | Anti-cll-1 antibodies and immunoconjugates | |
| MX2020011104A (es) | Composiciones farmaceuticas de compuestos terapeuticamente activos y sus metodos de uso. | |
| MX378168B (es) | Un extracto de indigo naturalis y un proceso para preparar el mismo. | |
| MX2022015248A (es) | Un anticuerpo anti-il-23a para usarse en el tratamiento de la enfermedad de crohn. | |
| MX2018002318A (es) | Proceso mejorado para producir fucoxantina y/o polisacaridos de microalgas. | |
| PL3142785T3 (pl) | Sposób wytwarzania alkenoli i ich zastosowanie do wytwarzania 1,3- butadienu | |
| PH12018501279A1 (en) | Compositions comprising 15-hepe and methods of using the same | |
| MA43650B1 (fr) | Formulations/compositions comprenant un inhibiteur de btk | |
| MX2017006019A (es) | Apilimod para uso en el tratamiento de melanoma. | |
| MX2020003762A (es) | Composiciones cosmeticas y metodo para tratar la piel. | |
| EP4480577A3 (en) | Structured elements and methods of use | |
| MX386624B (es) | Nuevos compuestos, su procedimiento de síntesis y su uso en medicina, así como cosmética. | |
| BR112017011285A2 (pt) | compostos intermediários para produzir ingredientes de perfumaria | |
| GEP201706795B (en) | Hexahydrofuropyrroles as pde1 inhibitors | |
| MX2017006899A (es) | Sintesis de polioles polimericos en polioles insaturados, polioles polimericos y su uso. | |
| PL409207A1 (pl) | Sposób wytwarzania produktu kosmetycznego | |
| EA201990181A1 (ru) | Получение активированных клостридиальных нейротоксинов |